Myfortic 180 mg (Tablet (Delayed Release))

Unit Price: ৳ 75.00 (12 x 10: ৳ 9,000.00)

Strip Price: ৳ 750.00

Medicine Details

Mycophenolic acid delayed-release tablets are enteric coated formulation of mycophenolate sodium
Immunosuppressive agent
Inhibitor of inosine monophosphate dehydrogenase (IMPDH)
Prevent acute rejection of kidney and heart allotransplantation
Decreases antibody production
Cytostatic effects on lymphocytes

Recommended dose of Mycophenolic acid is 720 mg administered twice daily (1440 mg total daily dose) for adult kidney transplant patients
Recommended dose of Mycophenolic acid in conversion (at least 6 months post-transplant) pediatric patients age 5 years and older is 400 mg/m2 body surface area (BSA) administered twice daily
Tablets should be taken on an empty stomach, 1 hour before or 2 hours after food intake
Tablets should not be crushed, chewed, or cut prior to ingesting

Caution should be exercised with concomitant administration of Antacids, Azathioprine, Cyclosporin, Rifampin, Sevelamer, Cholestyramine, Acyclovir, Metronidazole, Hormonal contraceptives as these medicines may decrease Myfortic concentration

Mycophenolic acid delayed-release tablets and Mycophenolate mofetil tablets and capsules should not be used interchangeably without physician supervision because the rate of absorption following the administration of these two products is not equivalent

Pregnancy Category D. Can cause fetal harm
Discontinue Mycophenolic acid or discontinue nursing while on treatment or within 6 weeks after stopping therapy. Take into consideration the importance of the drug to the mother

Can cause embryofetal toxicity
Can increase new or reactive viral infections
Can cause blood dyscrasias including pure red cell aplasia
Can cause serious GI tract complications (gastrointestinal bleeding, perforations and ulcers)
May increase the risk of developing lymphomas and other malignancies, particularly of the skin
Use of live vaccine should be avoided during treatment with Myfortic